SNOA

Sonoma Pharmaceuticals, Inc. [SNOA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SNOA Stock Summary

Top 10 Correlated ETFs

SNOA


Top 10 Correlated Stocks

SNOA


In the News

05:05 29 Sep 2023 SNOA

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Sonoma Pharmaceuticals shares jumped 44% on Friday after the company unveiled a product that could replace IV bags for some surgeries.

04:40 29 Sep 2023 SNOA

Markets End the Week in the Green in Anticipation the Fed Will Pause Rate Hikes

Markets posted a winning day on Friday, June 9, 2023, to top off a winning week on optimism the Fed may pause its interest rate hike cycle next week.

10:02 29 Sep 2023 SNOA

5 Penny Stocks To Watch With Big News This Week

Penny stocks to watch with news. The post 5 Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

09:30 29 Sep 2023 SNOA

7 Top Penny Stocks To Watch With Big News This Week

Penny Stocks With News Light Up The Scanners This Week This week

06:00 29 Sep 2023 SNOA

Why Investing in Penny Stocks Could Be Worth It

Are penny stocks worth investing in? The post Why Investing in Penny Stocks Could Be Worth It appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

09:23 29 Sep 2023 SNOA

Why Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?

Sonoma Pharmaceuticals (NASDAQ: SNOA ) stock is rocketing higher on Wednesday following positive news for its Microcyn Rx products. The big news here is Sonoma Pharmaceuticals getting a Distribution and Pricing Agreement (DAPA) from the Defense Logistics Agency ( DLA ).

06:00 29 Sep 2023 SNOA

What Makes Penny Stocks an Attractive Investment?

Are penny stocks on your watchlist right now? The post What Makes Penny Stocks an Attractive Investment?

01:13 29 Sep 2023 SNOA

Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?

Sonoma Pharmaceuticals (SNOA) stock is getting a boost on Tuesday after the company revealed positive disinfectant news from the EPA. The post Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?

09:33 29 Sep 2023 SNOA

Best Penny Stocks to Buy Today? 3 to Watch on May 3rd

What to know about buying penny stocks on May 3rd The post Best Penny Stocks to Buy Today? 3 to Watch on May 3rd appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

01:41 29 Sep 2023 SNOA

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

SNOA Financial details

Company Rating
Neutral
Market Cap
4.01M
Income
-5.68M
Revenue
12.72M
Book val./share
1.47
Cash/share
0.72
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
-0.68
Forward P/E
-
PEG
0.45
P/S
0.32
P/B
0.53
P/C
1.08
P/FCF
-0.79
Quick Ratio
1.48
Current Ratio
3.36
Debt / Equity
0.09
LT Debt / Equity
0.02
-
-
EPS (TTM)
-1.63
EPS next Y
-
EPS next Q
-
EPS this Y
-20.83%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-34.67%
Revenue last 5Y
-6.89%
Revenue Q/Q
13.7%
EPS Q/Q
-25.64%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
4.77%
Inst Trans
1.01%
ROA
-36%
ROE
-82%
ROC
-0.42%
Gross Margin
33%
Oper. Margin
-39%
Profit Margin
-45%
Payout
-
Shs Outstand
5.18M
Shs Float
4.89M
-
-
-
-
Target Price
-
52W Range
0.755-3.34
52W High
-
52W Low
-
RSI
36
Rel Volume
3.05
Avg Volume
24.3K
Volume
74K
Perf Week
2.24%
Perf Month
-8.59%
Perf Quarter
-19.06%
Perf Half Y
-32.43%
-
-
-
-
Beta
1.22925
-
-
Volatility
0.01%, 0.08%
Prev Close
-0.38%
Price
0.777
Change
-2.88%

SNOA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
Revenue per share
20.5312.829.334.763.91
Net income per share
-12.77-1.99-2.31-1.92-1.52
Operating cash flow per share
-12.68-3.11-1.69-1.6-1.81
Free cash flow per share
-12.79-3.25-1.78-1.65-1.89
Cash per share
3.992.52.112.791.13
Book value per share
11.355.892.693.282.35
Tangible book value per share
11.355.892.693.282.35
Share holders equity per share
11.355.892.693.282.35
Interest debt per share
0.551.011.350.510.25
Market cap
7.65M7.24M14.83M10.64M3.33M
Enterprise value
4.44M5.02M13.29M4.61M355.12K
P/E ratio
-0.65-2.46-3.21-2.09-0.65
Price to sales ratio
0.40.380.80.840.25
POCF ratio
-0.65-1.58-4.39-2.5-0.54
PFCF ratio
-0.65-1.51-4.17-2.43-0.52
P/B Ratio
0.730.832.771.220.42
PTB ratio
0.730.832.771.220.42
EV to sales
0.230.270.710.370.03
Enterprise value over EBITDA
-0.41-0.83-3.5-0.7-0.08
EV to operating cash flow
-0.38-1.09-3.93-1.09-0.06
EV to free cash flow
-0.38-1.05-3.73-1.05-0.06
Earnings yield
-1.54-0.41-0.31-0.48-1.55
Free cash flow yield
-1.54-0.66-0.24-0.41-1.93
Debt to equity
0.050.170.50.160.11
Debt to assets
0.030.10.180.070.05
Net debt to EBITDA
0.30.360.410.920.67
Current ratio
3.482.553.182.823.71
Interest coverage
-341.15-416.94-287.42588.7-285.63
Income quality
0.991.560.860.841.19
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.980000
Research and developement to revenue
0.080.070.030.010.02
Intangibles to total assets
00000
Capex to operating cash flow
0.010.040.050.030.04
Capex to revenue
-0.01-0.01-0.01-0.01-0.02
Capex to depreciation
-0.22-0.66-0.79-0.74-2.15
Stock based compensation to revenue
0.090.040.020.030.05
Graham number
57.1116.2611.8211.898.96
ROIC
-1.05-0.62-0.46-0.52-0.49
Return on tangible assets
-0.82-0.2-0.31-0.27-0.32
Graham Net
5.162-0.320.820.53
Working capital
8.91M7.52M8.91M10.61M10.08M
Tangible asset value
10.49M8.71M5.36M8.7M7.98M
Net current asset value
8.54M6.53M3.36M6.28M5.54M
Invested capital
0.050.170.50.160.11
Average receivables
2.99M4.91M5.01M4.72M5.6M
Average payables
1.26M1.67M1.93M1.71M1.24M
Average inventory
3.14M2.8M2.36M2.6M2.76M
Days sales outstanding
85.51103.4591.23138.1176.48
Days payables outstanding
45.471.8153.569.3634.9
Days of inventory on hand
123.3275.4676.51112.56118.61
Receivables turnover
4.273.5342.642.07
Payables turnover
8.045.086.825.2610.46
Inventory turnover
2.964.844.773.243.08
ROE
-1.12-0.34-0.86-0.58-0.65
Capex per share
-0.11-0.14-0.09-0.05-0.08

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q1

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
1.281.070.950.890.69
Net income per share
-0.29-0.33-0.62-0.39-0.29
Operating cash flow per share
-0.49-0.59-0.11-0.72-0.04
Free cash flow per share
-0.5-0.6-0.12-0.78-0.05
Cash per share
1.81.080.851.130.72
Book value per share
2.572.261.792.351.47
Tangible book value per share
2.572.261.792.351.47
Share holders equity per share
2.572.261.792.351.47
Interest debt per share
0.330.250.160.340.13
Market cap
9.05M6.61M3.48M3.33M5.28M
Enterprise value
4.42M4.03M1.33M355.12K2.39M
P/E ratio
-2.55-1.62-0.45-0.64-0.93
Price to sales ratio
2.271.981.181.11.54
POCF ratio
-5.91-3.61-10-1.36-24.57
PFCF ratio
-5.82-3.56-9.18-1.26-22.77
P/B Ratio
1.140.940.630.420.73
PTB ratio
1.140.940.630.420.73
EV to sales
1.111.210.450.120.7
Enterprise value over EBITDA
-5.37-5.73-0.74-0.32-2
EV to operating cash flow
-2.88-2.2-3.83-0.15-11.13
EV to free cash flow
-2.84-2.17-3.51-0.13-10.31
Earnings yield
-0.1-0.15-0.56-0.39-0.27
Free cash flow yield
-0.17-0.28-0.11-0.79-0.04
Debt to equity
0.120.110.090.110.09
Debt to assets
0.060.050.030.050.04
Net debt to EBITDA
5.623.671.192.672.42
Current ratio
3.053.512.863.713.36
Interest coverage
-12.76-243.67-1.83K-3.930
Income quality
1.731.80.181.870.15
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0000.070.09
Intangibles to total assets
00000
Capex to operating cash flow
0.020.010.090.080.08
Capex to revenue
-0.01-0.01-0.01-0.060
Capex to depreciation
-0.74-0.89-0.97-5.59-0.38
Stock based compensation to revenue
0.050.030.080.030.05
Graham number
4.064.095.014.513.08
ROIC
-0.09-0.1-0.29-0.11-0.15
Return on tangible assets
-0.05-0.07-0.14-0.08-0.09
Graham Net
-0.13-0.39-0.830.53-0.39
Working capital
9.96M8.87M7.3M10.08M9.55M
Tangible asset value
7.96M7.02M5.56M7.98M7.24M
Net current asset value
5.62M4.45M2.86M5.54M4.94M
Invested capital
0.120.110.090.110.09
Average receivables
3.61M2.46M2.39M4.36M4.43M
Average payables
1.85M1.57M1.19M1.07M965.5K
Average inventory
2.73M2.91M2.94M2.85M2.79M
Days sales outstanding
5567.270.22191.6264.05
Days payables outstanding
72.9748.4555.4635.244.13
Days of inventory on hand
98.9136.47121.35119.64110.53
Receivables turnover
1.641.341.280.471.41
Payables turnover
1.231.861.622.562.04
Inventory turnover
0.910.660.740.750.81
ROE
-0.11-0.14-0.35-0.16-0.2
Capex per share
-0.01-0.01-0.01-0.060

SNOA Frequently Asked Questions

What is Sonoma Pharmaceuticals, Inc. stock symbol ?

Sonoma Pharmaceuticals, Inc. is a US stock , located in Woodstock of Ga and trading under the symbol SNOA

What is Sonoma Pharmaceuticals, Inc. stock quote today ?

Sonoma Pharmaceuticals, Inc. stock price is $0.777 today.

Is Sonoma Pharmaceuticals, Inc. stock public?

Yes, Sonoma Pharmaceuticals, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap